Literature DB >> 28476706

Management of antibiotic-associated pseudomembranous colitis in Non-hospitalized and hospitalized patients.

Chun-Feng Tian1, Bai-Yu Su1, Yu-Juan Li1, Yu-Hong Tong1, Xu-Hong Zhao1, Jian-Ying Liang1, Shun-Bao Li2, Bu-Lang Gao3.   

Abstract

Proper management of antibiotic-associated pseudo membranous colitis is not clear. This article is to investigate proper treatment of antibiotic-associated pseudo membranous colitis. Data of 67 patients (aged 18-69 years, with 31 males and 46 females) with antibiotic-associated pseudo membranous colitis were retrospectively analyzed including the demography, antibiotics to induce and for treatment of the pseudo membranous colitis, and other supportive measures. All 67 patients had a positive cytotoxin test, which confirmed the pseudo membranous colitis. Antibiotics which induced the pseudo membranous colitis included clindamycin, ofloxacin, piperacillin, cefatriaxone, penbritin and ceftazidime. Once the correct diagnosis was made, the culprit antibiotics were discontinued immediately, and narrow-spectrum antibiotics like metronidazole and vancomycin were administered in combination with correction of fluid and electrolyte abnormalities, use of vitamins C and B complex to repair the intestinal mucosa, and avoidance of antispasmodic and antidiarrheal agents. After appropriate treatment for 2-20 days, all patients recovered with no sequela. Sixty-two patients were clinically cured while five (7.5%) had diarrhea recurrence within two months of the end of therapy. Retreatment with tapering and extended period of metronidazole and/or vancomycin led to complete recovery of the patients. Multiple antibiotic agents are associated with pseudo membranous colitis, and correction of fluid and electrolyte abnormalities and use of vitamins to repair the intestinal mucosa should be performed to speed up the cure process.

Entities:  

Mesh:

Year:  2016        PMID: 28476706

Source DB:  PubMed          Journal:  Pak J Pharm Sci        ISSN: 1011-601X            Impact factor:   0.684


  4 in total

1.  Enzyme Inhibitor Antibiotics and Antibiotic-Associated Diarrhea in Critically Ill Patients.

Authors:  Yanshu Zhang; Jingjing Sun; Jing Zhang; Yu Liu; Litao Guo
Journal:  Med Sci Monit       Date:  2018-12-04

2.  Risk Factors for Antibiotic-Associated Diarrhea in Critically Ill Patients.

Authors:  Guo Litao; Sun Jingjing; Liu Yu; Zhang Lei; He Xiaona; Zhu Zhijing
Journal:  Med Sci Monit       Date:  2018-07-18

3.  Peri-Implantitis: Application of a Protocol for the Regeneration of Deep Osseous Defects. A Retrospective Case Series.

Authors:  Simone Verardi; Nicola Alberto Valente
Journal:  Int J Environ Res Public Health       Date:  2021-12-01       Impact factor: 3.390

4.  Effects of Irrational Use of Antibiotics on Intestinal Health of Children with Extraintestinal Infectious Diseases.

Authors:  Xiaomei Guo; Lifu Sun; Shengjiang Wang; Yan Shen
Journal:  Contrast Media Mol Imaging       Date:  2022-08-18       Impact factor: 3.009

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.